The Problem W/ The 23andMe Cancer Test

Wochit - April 17, 2018

According to Business Insider, "The consumer genetics company 23andMe recently got a green light from the US Food and Drug Administration to include information on breast cancer risk in its online customer reports, based on screening for three of the multiple genetic mutations linked to the disease." Unfortunately, the new test may be misleading.

It's an at-home test that doesn't require a doctor's consultation..

Advertisement

Recent related videos


WEWS NewsChannel5 -   ▶  01:49



CBS 3 Philly -   ▶  00:53


You might like